Error Correction: Schedule of Error Corrections and Prior Period Adjustments (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
Jun. 30, 2025 |
| Schedule of Error Corrections and Prior Period Adjustments |
Adjustment
|
Treatment in these financial statements
|
R1 – Ecker Capital sale
|
ZenaTech, Inc. shares received as consideration ($10,471,466 at December 31, 2025) derecognized and related gains and losses reversed; the Company’s interest in Ecker Capital, LLC carried at nil (Note 6).
|
R2 – Bozki / VW Win mergers
|
Epazz, Inc. notes assumed in the mergers (principal $1,014,094; accrued interest $699,009 at December 31, 2025) and related interest derecognized; 50,000,000 conversion shares cancelled; commitment-fee amortization reversed.
|
R3 – Meridian note
|
Recognized with accrued interest and late charge (Note 10).
|
R4 – Equity
|
Shares issued for Galaxy Batteries (10,000,000,000) and the $37,000,000 common control adjustment account reversed; 366,000,000 shares issued in January 2025 under the voided compensation and management agreements cancelled and 2025 stock-based compensation of $477,722 ($183,000 in the 2025 periods presented) reversed; other shares issued to Dr. Passley and his affiliates and the Series B, C and D preferred stock cancelled (Note 11); reverse stock split rescinded. No effect on total equity.
|
R6 – Management fees
|
Fees of $479,565 billed by Epazz, Inc. under the voided Management Services Agreement and unpaid at December 31, 2025 derecognized from the beginning of the earliest period presented (Note 12).
|
|
|
Three months as previously reported
|
Adjustment
|
As restated
|
Six months as previously reported
|
Adjustment
|
As restated
|
Revenue
|
22,492
|
–
|
22,492
|
22,492
|
–
|
22,492
|
General and administrative
|
2,067
|
–
|
2,067
|
10,353
|
–
|
10,353
|
Stock-based compensation
|
183,000
|
(183,000)
|
–
|
183,000
|
(183,000)
|
–
|
Depreciation and amortization
|
2,000
|
–
|
2,000
|
4,000
|
–
|
4,000
|
Total operating expenses
|
187,067
|
(183,000)
|
4,067
|
197,353
|
(183,000)
|
14,353
|
Operating income (loss)
|
(164,575)
|
183,000
|
18,425
|
(174,861)
|
183,000
|
8,139
|
Interest expense
|
(28,623)
|
21,387
|
(7,236)
|
(55,615)
|
42,832
|
(12,783)
|
Gain (loss) on investment in securities
|
1,725,833
|
(1,725,833)
|
–
|
(7,296,262)
|
7,296,262
|
–
|
Net income (loss)
|
1,532,635
|
(1,521,446)
|
11,189
|
(7,526,738)
|
7,522,094
|
(4,644)
|
Weighted average shares – basic and diluted
|
949,226,791
|
|
368,015,948
|
949,226,791
|
|
382,933,075
|
Net income (loss) per share – basic and diluted
|
0.00
|
|
0.00
|
(0.01)
|
|
(0.00)
|
|
| December 31, 2025 Balance Sheet Restatement |
|
|
| Schedule of Error Corrections and Prior Period Adjustments |
|
As previously reported
|
Adjustment
|
As restated
|
Cash
|
2,543
|
–
|
2,543
|
Total current assets
|
2,543
|
–
|
2,543
|
Property and equipment, net
|
417,313
|
–
|
417,313
|
Franchise and development rights, net
|
78,375
|
–
|
78,375
|
Investment in securities
|
10,471,466
|
(10,471,466)
|
–
|
Total long-term assets
|
10,967,154
|
(10,471,466)
|
495,688
|
Total assets
|
10,969,697
|
(10,471,466)
|
498,231
|
Accounts payable
|
516,051
|
(479,565)
|
36,486
|
Accrued interest and expenses
|
700,642
|
(699,009)
|
1,633
|
Short-term debt
|
125,232
|
(104,232)
|
21,000
|
Short-term advances from affiliates
|
892,386
|
–
|
892,386
|
Amount due to Meridian Pacific Holdings, LLC
|
–
|
566,195
|
566,195
|
Total current liabilities
|
2,234,311
|
(716,611)
|
1,517,700
|
Long-term debt
|
935,065
|
(909,862)
|
25,203
|
Total long-term liabilities
|
935,065
|
(909,862)
|
25,203
|
Total liabilities
|
3,169,376
|
(1,626,473)
|
1,542,903
|
Preferred stock – Series A
|
74,887
|
–
|
74,887
|
Preferred stock – Series B
|
100,000
|
(100,000)
|
–
|
Preferred stock – Series C
|
599,890
|
(599,890)
|
–
|
Preferred stock – Series D
|
90,836
|
(90,836)
|
–
|
Preferred stock – Series E
|
230,000
|
–
|
230,000
|
Common stock
|
9,124
|
358,892
|
368,016
|
Additional paid-in capital
|
38,940,342
|
(37,045,888)
|
1,894,454
|
Common control adjustment account
|
(37,000,000)
|
37,000,000
|
–
|
Accumulated surplus (deficit)
|
4,755,242
|
(8,367,271)
|
(3,612,029)
|
Total stockholders’ equity (deficit)
|
7,800,321
|
(8,844,993)
|
(1,044,672)
|
Total liabilities and stockholders’ equity (deficit)
|
10,969,697
|
(10,471,466)
|
498,231
|
|
|
| March 31, 2026 Financial Statements Restatement |
|
|
| Schedule of Error Corrections and Prior Period Adjustments |
|
As previously reported
|
Adjustment
|
As restated
|
Revenue
|
5,419
|
–
|
5,419
|
General and administrative
|
8,223
|
–
|
8,223
|
Depreciation and amortization
|
8,208
|
–
|
8,208
|
Operating loss
|
(11,012)
|
–
|
(11,012)
|
Interest expense
|
(22,458)
|
16,512
|
(5,946)
|
Loss on investment in securities
|
(2,976,458)
|
2,976,458
|
–
|
Net loss
|
(3,009,928)
|
2,992,970
|
(16,958)
|
Weighted average shares – basic and diluted
|
9,131,485
|
|
368,015,948
|
Net loss per share – basic and diluted
|
(0.33)
|
|
(0.00)
|
Total stockholders’ equity (deficit), March 31, 2026
|
4,790,393
|
(5,852,023)
|
(1,061,630)
|
|
|